Spontaneous Dislocation and Adverse Events of a Prophylactic Pancreatic Stent

Starting soon · Not applicable

Conditions studied: Stent Dislodgement, ERCP, Pancreas Stent, Post-ERCP Pancreatitis, Prophylactic Pancreatic Stent

In brief

A multicenter, prospective, controlled randomized study to investigate the optimal duration of protective pancreatic stents after endoscopic retrograde cholangiopancreatography (ERCP). The primary endpoint is the complication rate that can be clinically attributed to the remaining pancreatic prosthesis or its removal in the study groups. Secondary endpoints are spontaneous removal of the pancreatic stent, length of hospital stay, rate of follow-up examinations per group, influencing factors, and a possible exploratory analysis.

Key facts

Study ID

NCT07346365

Run by

Johann Wolfgang Goethe University Hospital

People needed

358

Starts

2026-01-01

Expected to finish

2032-06-01

Last updated by the study team

2026-01-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• prophylactic pancreatic stent (5Fr 4cm length)
• informed consent

You may not qualify if…

• necrotising post-ercp-pancreatitis
• pregnancy/breastfeeding
• Billroth II

Where it is running

• Johann Wolfgang Goethe-Universität Frankfurt am Main — Frankfurt, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.